TFF Pharmaceuticals, Inc. (TFFP) is one of the Breakout Investor community’s favorite stocks. The name is an acronym for “thin film freezing” a technology developed by and licensed from the University of Texas. The technology is believed to have scores of opportunity, representing potentially billions in future revenue. On the Breakout Investor Platform (BIP) where […]
TFF Pharmaceuticals, Inc. has emerged as one of the favorite names within the Breakout Investors community. An early-stage biopharmaceutical company, TFFP is focused on developing and commercializing drug products based on its patented Thin Film Freezing, or TFF, technology platform. The initial focus on the development of inhaled dry powder drugs for the treatment of […]
B. Riley began coverage on shares of TFF Pharmaceuticals (NASDAQ:TFFP) in a research note released on Monday morning. The brokerage issued a buy rating and a $36.00 price objective on the stock. Summary and RecommendationWe are initiating coverage of TFF Pharmaceuticals, Inc. (TFFP) with a Buy rating and a 12-monthprice target of $36 per share. TFFP is building […]
TFFP shares are bouncing back today after three consecutive down days. Today’s high so far is $16.19, which is a 10% lift from yesterday’s closing price of $14.71. The move may be fueled because of a local news story by CBS Austin reporting that University of Texas professor Dr. Bill Williams is part of COVID-19 […]
Breakout Investors is: Community, Content, and Collaboration. We are a global network of investors eager to share ideas and research as we seek to identify future Breakout Investments.
